These countries include Ecuador, Eritrea, Ghana, Indonesia, Malaysia, Mozambique, South Africa, and Thailand.418 The Government of Thailand has moved with particular zeal in this direction by issuing a government use compulsory license on a remedy for heart disease in addition to HIV/AIDS drugs (see box 5). See A. Ahuja (Associated Press), “Thai Health Groups Urge Abbott Boycott”, IP health newsletter of 21 March 2007. For a critical assessment of such actions from a competition law standpoint, see S. Flynn, “Considering Competition Complaints Against Abbott in Thailand - A Brief Explanation of Potential Legal Arguments”, 23 March 2007 (available at http://www.wcl.american.edu/faculty/flynn/); and “Thailand’s Lawful Compulsory Licensing and Abbott’s Anticompetitive Response”, 26 April 2007 [hereinafter Flynn, Thailand’s Lawful Compulsory Licensing] (available at http://www.wcl.american.edu/faculty/flynn/).